Levy Kopelovich

Title: Innovations by Levy Kopelovich in Cancer Research

Introduction

Levy Kopelovich is a notable inventor based in Annandale, VA (US). He has made significant contributions to the field of cancer research, particularly in the identification of markers for early-stage human cancer. His innovative methods aim to enhance the understanding of cancer progression and recurrence.

Latest Patents

Kopelovich holds a patent for "Methods for identifying markers for early-stage human cancer, cancer progression and recurrence." This patent describes a method to identify secreted proteins associated with various stages of malignancy in cancer. The proteins are initially identified by trapping them with a fluorescent protein-containing vector that can insert into any gene. The secreted proteins are recognized by their fluorescence, allowing for the isolation of proteins that identify tumors with specific degrees of malignancy. This research has the potential to serve as a crucial tool in cancer progression monitoring.

Career Highlights

Throughout his career, Levy Kopelovich has worked with prominent organizations such as Anticancer, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to contribute to groundbreaking research in cancer detection and treatment.

Collaborations

Kopelovich has collaborated with esteemed colleagues, including Mingxu Xu and Yuying Tan. Their combined expertise has further advanced the research in identifying cancer markers and improving patient outcomes.

Conclusion

Levy Kopelovich's innovative work in cancer research exemplifies the importance of scientific advancements in the fight against cancer. His patented methods for identifying cancer markers represent a significant step forward in understanding and treating this complex disease.